{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:49:15Z","timestamp":1774702155118,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00203-026-04731-x","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:20:08Z","timestamp":1770884408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective cytotoxicity of microcin H47 against MDA-MB-231 breast cancer cells: an antimicrobial peptide with therapeutic potential"],"prefix":"10.1007","volume":"208","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0536-6071","authenticated-orcid":false,"given":"Farzaneh","family":"Mohammadzadeh Rostami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9105-6293","authenticated-orcid":false,"given":"Saman","family":"Shalibeik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"7","key":"4731_CR1","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1128\/AAC.01606-06","volume":"51","author":"MF Azpiroz","year":"2007","unstructured":"Azpiroz MF, Lavina M (2007) Modular structure of microcin H47 and colicin V. Antimicrob Agents Chemother 51(7):2412\u20132419","journal-title":"Antimicrob Agents Chemother"},{"issue":"24","key":"4731_CR2","doi-asserted-by":"publisher","first-page":"10393","DOI":"10.1007\/s00253-018-9420-8","volume":"102","author":"P Baindara","year":"2018","unstructured":"Baindara P, Korpole S, Grover V (2018) Bacteriocins: perspective for the development of novel anticancer drugs. Appl Microbiol Biotechnol 102(24):10393\u201310408","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"4731_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00248-010-9718-2","volume":"61","author":"E Ben-Dov","year":"2011","unstructured":"Ben-Dov E, Siboni N, Shapiro OH, Arotsker L, Kushmaro A (2011) Substitution by inosine at the 3\u2032-ultimate and penultimate positions of 16S rRNA gene universal primers. Microb Ecol 61(1):1\u20136","journal-title":"Microb Ecol"},{"issue":"1","key":"4731_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF02931286","volume":"48","author":"J Chumchalov\u00e1","year":"2003","unstructured":"Chumchalov\u00e1 J, \u0160marda J (2003) Human tumor cells are selectively inhibited by colicins. Folia Microbiol 48(1):111\u2013115","journal-title":"Folia Microbiol"},{"issue":"3","key":"4731_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/BF01964380","volume":"35","author":"J Fuska","year":"1979","unstructured":"Fuska J, Fuskov\u00e1 A, \u0160marda J, Mach J (1979) Effect of colicin E3 on leukemia cells P 388 in vitro. Experientia 35(3):406\u2013407","journal-title":"Experientia"},{"issue":"1","key":"4731_CR6","volume":"2018","author":"EN Gasu","year":"2018","unstructured":"Gasu EN, Ahor HS, Borquaye LS (2018) Peptide extract from Olivancillaria hiatula exhibits broad-spectrum antibacterial activity. BioMed Res Int 2018(1):6010572","journal-title":"BioMed Res Int"},{"issue":"2","key":"4731_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1046\/j.1365-2958.2003.03317.x","volume":"47","author":"M Goto","year":"2003","unstructured":"Goto M, Yamada T, Kimbara K, Horner J, Newcomb M, Gupta TD, Chakrabarty AM (2003) Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity. Mol Microbiol 47(2):549\u2013559","journal-title":"Mol Microbiol"},{"issue":"13","key":"4731_CR8","doi-asserted-by":"publisher","first-page":"5829","DOI":"10.1021\/jm5004478","volume":"57","author":"JD Hegemann","year":"2014","unstructured":"Hegemann JD, De Simone M, Zimmermann M, Knappe TA, Xie X, Di Leva FS, Marinelli L, Novellino E, Zahler S, Kessler H, Marahiel MA (2014) Rational improvement of the affinity and selectivity of integrin binding of grafted Lasso peptides. J Med Chem 57(13):5829\u20135834","journal-title":"J Med Chem"},{"issue":"5","key":"4731_CR9","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1073\/pnas.052709699","volume":"99","author":"C Hetz","year":"2002","unstructured":"Hetz C, Bono MR, Barros LF, Lagos R (2002) Microcin E492, a channel-forming bacteriocin from Klebsiella pneumoniae, induces apoptosis in some human cell lines. Proc Natl Acad Sci 99(5):2696\u20132701","journal-title":"Proc Natl Acad Sci"},{"key":"4731_CR10","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.2147\/OTT.S249756","volume":"11","author":"Z Huang","year":"2020","unstructured":"Huang Z, Yu P, Tang J (2020) Characterization of triple-negative breast cancer MDA-MB-231 cell spheroid model. Onco Targets Ther 11:5395\u20135405","journal-title":"Onco Targets Ther"},{"issue":"7","key":"4731_CR11","doi-asserted-by":"publisher","first-page":"e0131008","DOI":"10.1371\/journal.pone.0131008","volume":"10","author":"P Kamarajan","year":"2015","unstructured":"Kamarajan P, Hayami T, Matte B, Liu Y, Danciu T, Ramamoorthy A, Worden F, Kapila S, Kapila Y (2015) Nisin ZP, a bacteriocin and food preservative, inhibits head and neck cancer tumorigenesis and prolongs survival. PLoS ONE 10(7):e0131008","journal-title":"PLoS ONE"},{"issue":"2","key":"4731_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/pharmaceutics10020054","volume":"10","author":"TM Karpi\u0144ski","year":"2018","unstructured":"Karpi\u0144ski TM, Adamczak A (2018) Anticancer activity of bacterial proteins and peptides. Pharmaceutics 10(2):54","journal-title":"Pharmaceutics"},{"key":"4731_CR13","doi-asserted-by":"publisher","first-page":"1507286","DOI":"10.3389\/fmicb.2025.1507286","volume":"16","author":"DW Kavanaugh","year":"2025","unstructured":"Kavanaugh DW, Sivignon A, Rossez Y, Chouit Z, Chambon C, B\u00e9al L, Bonnet M, H\u00e9braud M, Gu\u00e9rardel Y, Nguyen HT, Barnich N (2025) Biochemical characterization of the Escherichia coli surfaceome: a focus on type I fimbriae and flagella. Front Microbiol 16:1507286","journal-title":"Front Microbiol"},{"issue":"39","key":"4731_CR14","doi-asserted-by":"publisher","first-page":"9278","DOI":"10.1039\/C6OB01815G","volume":"14","author":"GJ Kelly","year":"2016","unstructured":"Kelly GJ, Kia AF, Hassan F, O\u2019Grady S, Morgan MP, Creaven BS, McClean S, Harmey JH, Devocelle M (2016) Polymeric prodrug combination to exploit the therapeutic potential of antimicrobial peptides against cancer cells. Org Biomol Chem 14(39):9278\u20139286","journal-title":"Org Biomol Chem"},{"key":"4731_CR15","first-page":"1","volume":"24","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, Mutebi M, Garvey G, Soerjomataram I, Fidler-Benaoudia MM (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med 24:1\u20139","journal-title":"Nat Med"},{"issue":"1","key":"4731_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2174\/138920109787048643","volume":"10","author":"R Lagos","year":"2009","unstructured":"Lagos R, Tello M, Mercado G, Garc\u00eda V, Monasterio O (2009) Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin. Curr Pharm Biotechnol 10(1):74\u201385","journal-title":"Curr Pharm Biotechnol"},{"issue":"11","key":"4731_CR17","doi-asserted-by":"publisher","first-page":"6585","DOI":"10.1128\/jb.172.11.6585-6588.1990","volume":"172","author":"MA Lavi\u00f1a","year":"1990","unstructured":"Lavi\u00f1a MA, Gaggero C, Moreno F (1990) Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli. J Bacteriol 172(11):6585\u20136588","journal-title":"J Bacteriol"},{"issue":"4","key":"4731_CR18","first-page":"380","volume":"20","author":"S Liberio","year":"2013","unstructured":"Liberio S, Joanitti MA, Fontes G, Castro WS (2013) Anticancer peptides and proteins: a panoramic view. Protein Pept Lett 20(4):380\u2013391","journal-title":"Protein Pept Lett"},{"issue":"5","key":"4731_CR19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s10989-023-10545-y","volume":"29","author":"F Mohammadzadeh Rostami","year":"2023","unstructured":"Mohammadzadeh Rostami F, Moghim S, Javdan S, Nasr Esfahani B (2023) Antimicrobial efficacy and prevalence of microcins: low molecular mass bacteriocins produced by Escherichia coli. Int J Pept Res Ther 29(5):74","journal-title":"Int J Pept Res Ther"},{"key":"4731_CR20","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1128\/AAC.50.4.1411-1418.2006","volume":"50","author":"ME Poey","year":"2006","unstructured":"Poey ME, Azpiroz MF, Lavi\u00f1a M (2006) Chromosome-encoded microcins: a comparative analysis. Antimicrob Agents Chemother 50:1411\u20131418","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"4731_CR21","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1038\/sj.onc.1207376","volume":"23","author":"V Punj","year":"2004","unstructured":"Punj V, Bhattacharyya S, Saint-Dic D, Vasu C, Cunningham EA, Graves J, Yamada T, Constantinou AI, Christov K, White B, Li G (2004) Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene 23(13):2367\u20132378","journal-title":"Oncogene"},{"issue":"20","key":"4731_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/femsle\/fnab143","volume":"368","author":"L Rahimzadeh Torabi","year":"2021","unstructured":"Rahimzadeh Torabi L, Doudi M, Naghavi NS, Monajemi R (2021) Bacteriophages P\u0278En-CL and P\u0278En-HO can eliminate MDR Enterobacter cloacae and Enterobacter hormaechei isolated from burn wound infections without toxicity for human skin cells. FEMS Microbiol Lett 368(20):fnab143","journal-title":"FEMS Microbiol Lett"},{"key":"4731_CR23","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.3389\/fmicb.2019.01690","volume":"10","author":"G Rodrigues","year":"2019","unstructured":"Rodrigues G, Silva GG, Buccini DF, Duque HM, Dias SC, Franco OL (2019) Bacterial proteinaceous compounds with multiple activities toward cancers and microbial infection. Front Microbiol 10:1690","journal-title":"Front Microbiol"},{"issue":"9","key":"4731_CR24","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1128\/AAC.43.9.2176","volume":"43","author":"E Rodr\u00edguez","year":"1999","unstructured":"Rodr\u00edguez E, Gaggero C, Lavi\u00f1a M (1999) The structural gene for microcin H47 encodes a peptide precursor with antibiotic activity. Antimicrob Agents Chemother 43(9):2176\u20132182","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"4731_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1139\/w98-044","volume":"44","author":"E Rodr\u00edguez","year":"1998","unstructured":"Rodr\u00edguez E, Lavi\u00f1a M (1998) Genetic analysis of microcin H47 immunity. Can J Microbiol 44(7):692\u2013697","journal-title":"Can J Microbiol"},{"issue":"41","key":"4731_CR26","doi-asserted-by":"publisher","first-page":"12464","DOI":"10.1021\/ja0367703","volume":"125","author":"KJ Rosengren","year":"2003","unstructured":"Rosengren KJ, Clark RJ, Daly NL, G\u00f6ransson U, Jones A, Craik DJ (2003) Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone. J Am Chem Soc 125(41):12464\u201312474","journal-title":"J Am Chem Soc"},{"issue":"3","key":"4731_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.61186\/mlj.16.3.14","volume":"16","author":"S Shalibeik","year":"2022","unstructured":"Shalibeik S, Ghandehari F, Ahadi AM et al (2022) Antibacterial activity of the peptide microcin J25 produced by Escherichia coli. Med Lab J 16(3):14\u20138","journal-title":"Med Lab J"},{"issue":"1","key":"4731_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/pep2.24378","volume":"117","author":"S Shalibeik","year":"2025","unstructured":"Shalibeik S, Ghandehari F, Ahadi AM, Rastegari AA, Ghiasian M (2025) Protective effects of antimicrobial peptide microcin J25 (MccJ25) isolated from Escherichia coli against breast cancer cells. Pept Sci 117(1):e24378","journal-title":"Pept Sci"},{"key":"4731_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jconrel.2018.07.030","volume":"286","author":"ON Shilova","year":"2018","unstructured":"Shilova ON, Shilov ES, Lieber A, Deyev SM (2018) Disassembling a cancer puzzle: cell junctions and plasma membrane as targets for anticancer therapy. J Controlled Release 286:125\u2013136","journal-title":"J Controlled Release"},{"key":"4731_CR30","doi-asserted-by":"publisher","first-page":"780355","DOI":"10.3389\/fmicb.2021.780355","volume":"12","author":"S Soltani","year":"2022","unstructured":"Soltani S, Zirah S, Rebuffat S, Couture F, Boutin Y, Biron E, Subirade M, Fliss I (2022) Gastrointestinal stability and cytotoxicity of bacteriocins from Gram-positive and Gram-negative bacteria: a comparative in vitro study. Front Microbiol 12:780355","journal-title":"Front Microbiol"},{"issue":"3","key":"4731_CR31","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1021\/acs.molpharmaceut.6b00652","volume":"14","author":"R Soudy","year":"2017","unstructured":"Soudy R, Etayash H, Bahadorani K, Lavasanifar A, Kaur K (2017) Breast cancer targeting peptide binds keratin 1: a new molecular marker for targeted drug delivery to breast cancer. Mol Pharm 14(3):593\u2013604","journal-title":"Mol Pharm"},{"issue":"3","key":"4731_CR32","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijmm.2007.01.008","volume":"297","author":"J Stritzker","year":"2007","unstructured":"Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA (2007) Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol 297(3):151\u2013162","journal-title":"Int J Med Microbiol"},{"key":"4731_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fmicb.2020.00405","volume":"11","author":"MA Varas","year":"2020","unstructured":"Varas MA, Mu\u00f1oz-Montecinos C, Kallens V, Simon V, Allende ML, Marcoleta AE, Lagos R (2020) Exploiting zebrafish xenografts for testing the in vivo antitumorigenic activity of microcin E492 against human colorectal cancer cells. Front Microbiol 11:405","journal-title":"Front Microbiol"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-04731-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-04731-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T12:00:24Z","timestamp":1774699224000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-026-04731-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4731"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-04731-x","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"192"}}